Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
19 May 2024
|
|
m 01:07 | Diffuse large B-cell lymphoma 2 changes history +66 [Jwarner (2×)] | |||
| m |
|
01:07 (cur | prev) +21 Jwarner talk contribs →R-ESHAP {{#subobject:7794d|Regimen=1}} | |||
| m |
|
01:05 (cur | prev) +45 Jwarner talk contribs →Regimen {{#subobject:b6038c|Variant=1}} | |||
| m 00:56 | Multiple myeloma - historical diffhist +39 Jwarner talk contribs →CVP {{#subobject:fdb4g3|Regimen=1}} | ||||
| m 00:53 | Breast cancer - historical diffhist +55 Jwarner talk contribs →CTCb, then auto HSCT {{#subobject:7a4fec|Regimen=1}} | ||||
| m 00:51 | Head and neck cancer diffhist +21 Jwarner talk contribs →Regimen variant #7, 100/3000 x 2 {{#subobject:dd2jgu|Variant=1}} | ||||
| m 00:38 | Mantle cell lymphoma diffhist +17 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} | ||||
| m 00:29 | Multiple myeloma, consolidation and maintenance diffhist +101 Jwarner talk contribs →Thalidomide & Prednisolone (TP) {{#subobject:1agdc9|Regimen=1}} | ||||
18 May 2024
|
|
m 14:25 | B-cell acute lymphoblastic leukemia 2 changes history +48 [Jwarner (2×)] | |||
| m |
|
14:25 (cur | prev) +27 Jwarner talk contribs →Regimen variant #4, 50/6000/2/60 ("Linker regimen") {{#subobject:9ce40a|Variant=1}} | |||
| m |
|
01:23 (cur | prev) +21 Jwarner talk contribs →Regimen {{#subobject:cf4hg1|Variant=1}} | |||
|
|
m 11:56 | HIV-associated lymphoma 2 changes history +269 [Jwarner (2×)] | |||
| m |
|
11:56 (cur | prev) +180 Jwarner talk contribs | |||
| m |
|
11:52 (cur | prev) +89 Jwarner talk contribs →CVP {{#subobject:1a817a|Regimen=1}} | |||
| m 11:50 | Acute myeloid leukemia diffhist +292 Jwarner talk contribs →CLAG {{#subobject:702383|Regimen=1}} | ||||
|
|
m 11:44 | Diffuse large B-cell lymphoma - historical 2 changes history +72 [Jwarner (2×)] | |||
| m |
|
11:44 (cur | prev) +40 Jwarner talk contribs →CHVP {{#subobject:15cj69|Regimen=1}} | |||
| m |
|
11:42 (cur | prev) +32 Jwarner talk contribs →CHVmP-VB {{#subobject:0a9c69|Regimen=1}} | |||
|
|
m 01:16 | Acute promyelocytic leukemia 3 changes history +206 [Jwarner (3×)] | |||
| m |
|
01:16 (cur | prev) +17 Jwarner talk contribs →ATRA monotherapy {{#subobject:45c33c|Regimen=1}} | |||
| m |
|
01:13 (cur | prev) +94 Jwarner talk contribs | |||
| m |
|
01:12 (cur | prev) +95 Jwarner talk contribs →Regimen variant #3, 0.3/45 {{#subobject:e391b9|Variant=1}} | |||
|
|
m 01:07 | Plasma cell leukemia 2 changes history +166 [Jwarner (2×)] | |||
| m |
|
01:07 (cur | prev) +75 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:bec321|Regimen=1}} | |||
| m |
|
01:06 (cur | prev) +91 Jwarner talk contribs →Consolidation after first-line therapy | |||
| m 01:03 | Myelodysplastic syndrome diffhist +412 Jwarner talk contribs | ||||
| m 00:56 | Multiple myeloma, consolidation and maintenance diffhist +589 Jwarner talk contribs | ||||
| m 00:43 | Nasopharyngeal carcinoma diffhist +35 Jwarner talk contribs | ||||
17 May 2024
| m 22:05 | Urothelial carcinoma diffhist +2,836 Jwarner talk contribs | ||||
| 18:50 | Small cell lung cancer diffhist +1,494 Jwarner talk contribs →Temozolomide monotherapy {{#subobject:693cf4|Regimen=1}} | ||||
| m 18:28 | Follicular lymphoma diffhist +636 Jwarner talk contribs | ||||
| m 18:26 | High-grade B-cell lymphoma diffhist +468 Jwarner talk contribs | ||||
| m 18:26 | Primary mediastinal B-cell lymphoma diffhist +469 Jwarner talk contribs | ||||
| m 18:25 | Transformed lymphoma diffhist +468 Jwarner talk contribs | ||||
| m 18:25 | Diffuse large B-cell lymphoma diffhist +468 Jwarner talk contribs →References | ||||
| m 16:51 | PEComa diffhist +582 Jwarner talk contribs →References | ||||
|
|
16:39 | Prostate cancer 8 changes history +4,033 [Jwarner (8×)] | |||
| m |
|
16:39 (cur | prev) -46 Jwarner talk contribs | |||
| m |
|
16:35 (cur | prev) +4 Jwarner talk contribs →ADT {{#subobject:6e0da9|Regimen=1}} | |||
| m |
|
16:34 (cur | prev) -56 Jwarner talk contribs →ADT {{#subobject:8ab01b|Regimen=1}} | |||
| m |
|
16:33 (cur | prev) +262 Jwarner talk contribs | |||
| m |
|
16:26 (cur | prev) -1,824 Jwarner talk contribs | |||
|
|
15:47 (cur | prev) +5,689 Jwarner talk contribs →ADT {{#subobject:6e0da9|Regimen=1}} | ||||
| m |
|
15:27 (cur | prev) +1 Jwarner talk contribs →Hormonal therapy for metastatic or locally advanced disease | |||
| m |
|
15:26 (cur | prev) +3 Jwarner talk contribs →ADT {{#subobject:68ajcbz|Regimen=1}} | |||
| m 16:22 | Prostate cancer - historical diffhist -27 Jwarner talk contribs | ||||
|
|
m 16:21 | Breast cancer 2 changes history -12 [Jwarner (2×)] | |||
| m |
|
16:21 (cur | prev) +5 Jwarner talk contribs | |||
| m |
|
16:15 (cur | prev) -17 Jwarner talk contribs | |||
| m 15:54 | Acute myeloid leukemia diffhist +698 Jwarner talk contribs →References | ||||
| m 12:41 | Colorectal cancer diffhist +1,635 Jwarner talk contribs →CapeOx & Bevacizumab {{#subobject:62d39f|Regimen=1}} | ||||
16 May 2024
| m 10:55 | Non-small cell lung cancer diffhist -80 Jwarner talk contribs →References | ||||
|
|
m 00:45 | Venous thromboembolism 2 changes history -6,404 [Jwarner (2×)] | |||
| m |
|
00:45 (cur | prev) -6,662 Jwarner talk contribs →VTE primary prophylaxis | |||
| m |
|
00:42 (cur | prev) +258 Jwarner talk contribs | |||
| N 00:44 | Venous thromboembolism - null regimens diffhist +7,848 Jwarner talk contribs Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;..." | ||||
| N 00:40 | Follicular lymphoma - null regimens diffhist +25,429 Jwarner talk contribs Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;..." | ||||